Teva finds positive results in advanced trials for asthma drug – Yahoo News


Globes

Teva finds positive results in advanced trials for asthma drug
Yahoo News
TEL AVIV (Reuters) – Teva Pharmaceutical Industries said a drug under development had positive results in reducing the frequency of clinical asthma exacerbations in two advanced trials in patients with moderate to severe asthma. Reslizumab, an …
Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical StudiesRTT News
Teva reports positive Phase III asthma drug resultsGlobes

all 5 news articles »

View full post on asthma – Google News

Teva finds positive results in advanced trials for asthma drug – Reuters


Globes

Teva finds positive results in advanced trials for asthma drug
Reuters
Reslizumab, an investigational antibody, showed statistically significant reductions in the frequency of asthma exacerbations – episodes of progressively worsening shortness of breath, coughing, wheezing, and chest tightness – compared to patients
Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical StudiesRTT News
Teva reports positive Phase III asthma drug resultsGlobes

all 4 news articles »

View full post on asthma – Google News

Avoidable asthma deaths: national audit results – Nursing Times


Belfast Telegraph

Avoidable asthma deaths: national audit results
Nursing Times
The aim of the review was to build on previous confidential enquires into asthma deaths that have taken place around the UK to provide a robust body of evidence to help understand how these events arise and how they might be avoided in the future.
More than a million people suffering from asthma are missing out on key yearly Belfast Telegraph
Concern over people with asthma missing key medicine checksRochdale Online
Asthma patients 'risk lives' by skipping annual checksBBC News
ITV News –Huffington Post UK
all 19 news articles »

View full post on asthma – Google News

Asmacure Posts Promising Phase 1/2a Asthma Drug Results – Drug Discovery & Development


Drug Discovery & Development

Asmacure Posts Promising Phase 1/2a Asthma Drug Results
Drug Discovery & Development
"The pharmacokinetics data from this study provided important information on the potential dose range for ASM-024 in the treatment of the moderate asthma patient when delivered as a dry powder for inhalation." ASM-024 is under development in a dry …

View full post on asthma – Google News

Early child life Bacteria infection results to Asthma and Allergy protection – The Westside Story

Early child life Bacteria infection results to Asthma and Allergy protection
The Westside Story
Babies who are exposed to bacteria within the first year of their life will be less likely to develop asthma and allergies later on, a new study finds. The new study finds that babies exposed to certain types of bacteria may be less likely to get

View full post on asthma – Google News

Amgen Posts Positive Phase I Results For Asthma Drug – BioResearch Online (press release)

Amgen Posts Positive Phase I Results For Asthma Drug
BioResearch Online (press release)
Amgen reported positive results from the Phase I study showing that inhibiting thymic stromal lymphopoietin (TSLP) could be useful in the treatment of asthma. TSLP is a cytokine considered to be a key driver of the allergic inflammation that
Anti-thymic stromal lymphopoietin therapy reduced allergy-induced Healio

all 3 news articles »

View full post on asthma – Google News

Atopix reports positive results from Phase IIb asthma study with OC459 compound – News-Medical.net

Atopix reports positive results from Phase IIb asthma study with OC459 compound
News-Medical.net
Atopix Therapeutics Ltd ("Atopix"), a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the results of a Phase IIb asthma study with their lead compound OC459 at the American Academy of Allergy, Asthma 

and more »

View full post on asthma – Google News

Basic cancer research at Creighton yields promising results for diagnosing … – News-Medical.net

Basic cancer research at Creighton yields promising results for diagnosing
News-Medical.net
What started as basic cancer research at Creighton University has yielded promising results for diagnosing and treating asthma – and the National Institutes of Health (NIH) agrees, investing nearly $1.5 million in Creighton to find out more. In a

View full post on asthma – Google News